http://orcid.org/0000-0002-3553-2491
Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
T. E. Robsahm, K. M. Tsuruda, H. H. Hektoen, A. H. Storås, M. B. Cook, L. M. Hurwitz & H. Langseth. (2023) Applying recommended definition of aggressive prostate cancer: a validation study using high-quality data from the Cancer Registry of Norway. Acta Oncologica 62:1, pages 8-14.
Read now
Read now
Oskar Bergengren & Marcus Westerberg. (2022) Watch out for sticky diagnosis bias in older men with prostate cancer. Scandinavian Journal of Urology 56:5-6, pages 365-366.
Read now
Read now
Kaire Innos, Keiu Paapsi, Indrek Alas, Peep Baum, Martin Kivi, Mihhail Kovtun, Rauno Okas, Helis Pokker, Olga Rajevskaja, Aleksandra Rautio, Mikk Saretok, Elari Valk, Mihhail Žarkovski, Gleb Denissov & Katrin Lang. (2022) Evidence of overestimating prostate cancer mortality in Estonia: a population-based study. Scandinavian Journal of Urology 56:5-6, pages 359-364.
Read now
Read now
Anton Barchuk, Rustam Tursun-zade, Alexey Belayev, Malcolm Moore, Yuri Komarov, Nataliia Moshina, Ahti Anttila, Jaakko Nevalainen, Anssi Auvinen, Anton Ryzhov & Ariana Znaor. (2021) Comparability and validity of cancer registry data in the northwest of Russia. Acta Oncologica 60:10, pages 1264-1271.
Read now
Read now
Sven Löffeler, Adrian Halland, Haris Fawad, Christian Beisland & Erik S. Haug. (2020) Non-metastatic prostate cancer: rationale for conservative treatment and impact on disease-related morbidity and mortality in the elderly. Scandinavian Journal of Urology 54:2, pages 105-109.
Read now
Read now
Articles from other publishers (18)
H.V. Stroomberg, A. Røder, J.T. Helgstrand, K. Brasso & S.B. Larsen. (2023) Evaluation of causes of death among Danish men with initial non-malignant histopathology of the prostate. Ethics, Medicine and Public Health 30, pages 100930.
Crossref
Crossref
Tor Åge Myklebust, Bjarte Aagnes, Yngvar Nilssen, Mark Rutherford, Paul C. Lambert, Therese M. L. Andersson, Anna L. V. Johansson, Paul W. Dickman & Bjørn Møller. (2023) Improving communication of cancer survival statistics—feasibility of implementing model-based algorithms in routine publications. British Journal of Cancer 129:5, pages 819-828.
Crossref
Crossref
Bjørn Hofmann, Erik Skaaheim Haug, Eivind Richter Andersen & Elin Kjelle. (2022) Increased magnetic resonance imaging in prostate cancer management—What are the outcomes?. Journal of Evaluation in Clinical Practice 29:6, pages 893-902.
Crossref
Crossref
Tofigh Mobaderi, Anoshirvan Kazemnejad & Masoud Salehi. (2023) Bayesian clustering of 109 worldwide countries according to the trend of prostate cancer mortality rates from 1990 to 2019. PLOS ONE 18:8, pages e0290110.
Crossref
Crossref
Andri Wilberg Orrason, Johan Styrke, Hans Garmo & Pär Stattin. (2022) Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden. BJU International 131:4, pages 486-493.
Crossref
Crossref
Justus Domschikowski, Karoline Koch & Claudia Schmalz. (2021) Cause of Death in Patients in Radiation Oncology. Frontiers in Oncology 11.
Crossref
Crossref
Sanny Kappen, Geertruida H. de Bock, Eunice Sirri, Claudia Vohmann, Joachim Kieschke & Alexander Winter. (2021) Differences in Prostate Cancer Incidence and Mortality in Lower Saxony (Germany) and Groningen Province (Netherlands): Potential Impact of Prostate-Specific Antigen Testing. Frontiers in Oncology 11.
Crossref
Crossref
Kirsti Aas, Viktor Berge, Tor Åge Myklebust & Sophie Dorothea Fosså. (2021) Comparative Survival Outcomes of High-risk Prostate Cancer Treated with Radical Prostatectomy or Definitive Radiotherapy Regimens. European Urology Open Science 26, pages 55-63.
Crossref
Crossref
Carlos Anselmo Lima, Brenda Evelin Barreto da Silva, Evânia Curvelo Hora, Marcela Sampaio Lima, Erika de Abreu Costa Brito, Marceli de Oliveira Santos, Angela Maria da Silva, Marco Antonio Prado Nunes, Hugo Leite de Farias Brito & Marcia Maria Macedo Lima. (2021) Trends in prostate cancer incidence and mortality to monitor control policies in a northeastern Brazilian state. PLOS ONE 16:3, pages e0249009.
Crossref
Crossref
Samuel William David Merriel, Suzanne Marie Ingle, Margaret T May & Richard M Martin. (2021) Retrospective cohort study evaluating clinical, biochemical and pharmacological prognostic factors for prostate cancer progression using primary care data. BMJ Open 11:2, pages e044420.
Crossref
Crossref
Sophie D. Fosså, Kirsti Aas, Christoph. Müller, Marianne B. Jerm, Torgrim Tandstad, Wolfgang Lilleby, Rune Kvåle, Johanne Gulbrandsen, Erik Haug & Tor A. Myklebust. (2021) Definitive radiotherapy for prostate cancer in Norway 2006–2015: Temporal trends, performance and survival. Radiotherapy and Oncology 155, pages 33-41.
Crossref
Crossref
Kirsti Aas, Sophie Dorothea Fosså, Tor Åge Myklebust, Bjørn Møller, Rune Kvåle, Ljiljana Vlatkovic & Viktor Berge. (2020) Increased curative treatment is associated with decreased prostate cancer‐specific and overall mortality in senior adults with high‐risk prostate cancer; results from a national registry‐based cohort study. Cancer Medicine 9:18, pages 6646-6657.
Crossref
Crossref
Sofie Sebuødegård, Edoardo Botteri & Solveig Hofvind. (2020) Breast Cancer Mortality After Implementation of Organized Population-Based Breast Cancer Screening in Norway. JNCI: Journal of the National Cancer Institute 112:8, pages 839-846.
Crossref
Crossref
Chloe J. Bright, Adam R. Brentnall, Kate Wooldrage, Jonathon Myles, Peter Sasieni & Stephen W. Duffy. (2020) Errors in determination of net survival: cause-specific and relative survival settings. British Journal of Cancer 122:7, pages 1094-1101.
Crossref
Crossref
Bjørg Y. Aksnessæther, Tor Åge Myklebust, Arne Solberg, Olbjørn H. Klepp, Eva Skovlund, Solveig Roth Hoff, Sophie D. Fosså, Anders Widmark & Jo-Åsmund Lund. (2020) Second Cancers in Patients With Locally Advanced Prostate Cancer Randomized to Lifelong Endocrine Treatment With or Without Radical Radiation Therapy: Long-Term Follow-up of the Scandinavian Prostate Cancer Group-7 Trial. International Journal of Radiation Oncology*Biology*Physics 106:4, pages 706-714.
Crossref
Crossref
Rune Kvåle, Tor Å. Myklebust, Sophie D. Fosså, Kirsti Aas, Christian Ekanger, Svein I. Helle, Alfred Honoré & Bjørn Møller. (2019) Impact of positive surgical margins on secondary treatment, palliative radiotherapy and prostate cancer‐specific mortality. A population‐based study of 13 198 patients. The Prostate 79:16, pages 1852-1860.
Crossref
Crossref
Ausvydas Patasius, Kaire Innos, Anton Barchuk, Anton Ryzhov, Marcis Leja, Janis Misins, Alesya Yaumenenka & Giedre Smailyte. (2019) Prostate cancer incidence and mortality in the Baltic states, Belarus, the Russian Federation and Ukraine. BMJ Open 9:10, pages e031856.
Crossref
Crossref
Michel D. Wissing, Zoë R. Greenwald & Eduardo L. Franco. (2019) Improving the reporting of cancer-specific mortality and survival in research using cancer registry data. Cancer Epidemiology 59, pages 232-235.
Crossref
Crossref